- Home
- Publications
- Publication Search
- Publication Details
Title
Toxoplasma gondii and schizophrenia: a review of published RCTs
Authors
Keywords
<em class=EmphasisTypeItalic >Toxoplasma</em>, Schizophrenia, Treatment, Chronic
Journal
PARASITOLOGY RESEARCH
Volume 116, Issue 7, Pages 1793-1799
Publisher
Springer Nature
Online
2017-05-16
DOI
10.1007/s00436-017-5478-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Artemisinin and its derivatives in treating protozoan infections beyond malaria
- (2017) Cecilia Shi Ni Loo et al. PHARMACOLOGICAL RESEARCH
- The efficacy of herbal medicines against Toxoplasma gondii during the last 3 decades: a systematic review
- (2016) Mahdi Sharif et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- The known and missing links between Toxoplasma gondii and schizophrenia
- (2016) Hany M. Elsheikha et al. METABOLIC BRAIN DISEASE
- Beyond the association.Toxoplasma gondiiin schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis
- (2015) A. L. Sutterland et al. ACTA PSYCHIATRICA SCANDINAVICA
- Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity
- (2015) Andrew J. Neville et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Could miltefosine be used as a therapy for toxoplasmosis?
- (2015) Maha M. Eissa et al. EXPERIMENTAL PARASITOLOGY
- Schizophrenia andToxoplasma gondii: an undervalued association?
- (2015) Jaroslav Flegr Expert Review of Anti-Infective Therapy
- Association between latent toxoplasmosis and clinical course of schizophrenia - continuous course of the disease is characteristic for Toxoplasma gondii-infected patients
- (2015) Tuncay Celik et al. FOLIA PARASITOLOGICA
- Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: A cross-sectional study
- (2015) Guillaume Fond et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes
- (2014) Jitka Lindova et al. FOLIA PARASITOLOGICA
- Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials
- (2014) Kazuto Oya et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A Thiazole Derivative of Artemisinin Moderately ReducesToxoplasma gondiiCyst Burden in Infected Mice
- (2014) Tracey L. Schultz et al. JOURNAL OF PARASITOLOGY
- The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii
- (2014) Hui-Ling Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Meta-Analysis of Anti-Toxoplasma gondiiIgM Antibodies in Acute Psychosis
- (2014) Joel M. Monroe et al. SCHIZOPHRENIA BULLETIN
- Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate
- (2013) Guillaume Fond et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia
- (2012) D. Holub et al. ACTA PSYCHIATRICA SCANDINAVICA
- Significant Reduction of Brain Cysts Caused by Toxoplasma gondii after Treatment with Spiramycin Coadministered with Metronidazole in a Mouse Model of Chronic Toxoplasmosis
- (2012) Wai Kit Chew et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis
- (2012) J. Flegr JOURNAL OF EXPERIMENTAL BIOLOGY
- Evaluation of Five Antischizophrenic Agents Against Toxoplasma gondii in Human Cell Cultures
- (2011) David G. Goodwin et al. JOURNAL OF PARASITOLOGY
- Artemisinin reduces the level of antibodies to gliadin in schizophrenia
- (2011) Faith Dickerson et al. SCHIZOPHRENIA RESEARCH
- Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: Voxel-based-morphometry (VBM) study
- (2011) Jiri Horacek et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays
- (2010) Vesna Munić et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Thiazole, Oxadiazole, and Carboxamide Derivatives of Artemisinin are Highly Selective and Potent Inhibitors ofToxoplasma gondii
- (2010) Christopher P. Hencken et al. JOURNAL OF MEDICINAL CHEMISTRY
- Artemisone and Artemiside Control Acute and Reactivated Toxoplasmosis in a Murine Model
- (2009) I. R. Dunay et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
- (2009) Georgios Pappas et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Trimethoprim as Adjuvant Treatment in Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
- (2009) T. Shibre et al. SCHIZOPHRENIA BULLETIN
- A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii
- (2009) Faith B. Dickerson et al. SCHIZOPHRENIA RESEARCH
- Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
- (2007) Yuko Fujita et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started